Work

Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma

Year: 2012

Type: article

Study design: Clinical Trial

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.3109/10428194.2012.710328

Authors: Andres Forero-Torres, Nancy Bartlett, Anne Beaven, Han Myint, Sunita Nasta, Donald W. Northfelt, Nancy C. Whiting, Jonathan G. Drachman, Albert F. LoBuglio, Craig H. Moskowitz

Institutions: University of Alabama at Birmingham, Washington University in St. Louis, Duke University, University of Colorado Denver, University of Pennsylvania, Mayo Clinic in Arizona, Seagen (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: University of Alabama at Birmingham

OpenAlex ID: W2165031233

FWCI: 4.773

Cites: 31

Cited by: 43

Related to: 10